Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Myocardial Infarction In Patients With Intracerebral Hemorrhage. Prevalence And Impact On Outcome
Cerebrovascular Disease and Interventional Neurology
Cerebrovascular Disease and Interventional Neurology Posters (7:00 AM-5:00 PM)
084
Comorbidities can potentially affect outcome of patients with intracerebral
hemorrhage (ICH). It is unclear what the prevalence of acute myocardial infarction (AMI) and its impact on outcome are in patients with intracerebral hemorrhage.
NA
We analyzed the data from Nationwide Inpatient
Sample (2005-2014) for all intracerebral hemorrhage (ICH) patients. AMI was identified using the International
Classification of Disease, 9th Revision, Clinical Modification codes. Baseline characteristics, discharge outcomes
(mortality, discharge disposition, length of stay and in-hospital charges) were compared between the two groups.
Results:Of the 884379 patients with ICH, 27692 (3.13%) had in-hospital myocardial infraction. ICH patients withAMI order had lower proportion of females (47.8% versus 49.7%, P= 0.0028) and were older (69.7 years versus 67.2years, P <.0001) compared to ICH patients without MI. The in-hospital mortality was higher (40.9% versus 25.5%,p≤.0001) among ICH patients with AMI in both univariate and multivariate analysis (OR = 1.22 (1.14 -1.31),P<.0001) after adjusting for potential confounders. ICH patients with MI had higher (72.4% versus 58.8%, P <.0001)proportion of moderate to severe disability at discharge compared to ones without. Similarly, mean length of in- hospital stay (12.4 days versus 8.94 days, P <.0001) and mean hospital charges ($129328 versus $ 81984.0, P<.0001) were also higher in ICH patients with MI
Conclusions:While only 3.13% of patients with ICH have an AMI,
there is a 22% increase in worse outcome among those patients with AMI and ICH.
Authors/Disclosures
Mohammad Ghatali, MD (Texas Tech Health Science Center)
PRESENTER 		Dr. Ghatali has nothing to disclose.
Baljinder Singh, MD Dr. Singh has nothing to disclose.
Hussan Gill Mr. Gill has nothing to disclose.
Mohammad Rauf A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Harathi Bandaru, MD Dr. Bandaru has nothing to disclose.
Sushma R. Yerram, MD (Texas tech University of Health Sciences) Dr. Yerram has nothing to disclose.
Anantha Vellipuram, MD Dr. Vellipuram has nothing to disclose.
Paisith Piriyawat, MD (Texas Tech University) Dr. Piriyawat has nothing to disclose.
Salvador Cruz-Flores, MD, FÂ鶹´«Ã½Ó³»­ (Paul L. Foster School of Medicine Texas Tech University Health Sciences Center) The institution of Dr. Cruz-Flores has received research support from University of Texas System.